Patents by Inventor Audrey Odom

Audrey Odom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosing malaria
    Patent number: 11925455
    Abstract: Various methods of diagnosing and monitoring a subject infected with a Plasmodium parasite are described. Also, compositions and methods for attracting mosquitos are also described.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: March 12, 2024
    Assignee: Washington University
    Inventors: Audrey Odom John, Chad Schaber, Indi Trehan, Baranidharan Raman, Nalin Katta
  • ANTIBIOTICS FOR VETERINARY STAPHYLOCOCCAL INFECTIONS
    Publication number: 20210261580
    Abstract: The present disclosure provides method of treating or preventing a microbial infection caused by a prokaryotic pathogen in a subject, the method comprising administering a compound of Formula (I) as set forth in the specification. In one embodiment, the prokaryotic pathogen belongs to the genus Staphylococcus.
    Type: Application
    Filed: June 18, 2019
    Publication date: August 26, 2021
    Inventors: CYNTHIA DOWD, AUDREY ODOM JOHN, RACHEL EDWARDS, KENNETH M. HEIDEL, XU WANG, RENE CHOFOR
  • METHODS FOR DIAGNOSING MALARIA
    Publication number: 20210128016
    Abstract: Various methods of diagnosing and monitoring a subject infected with a Plasmodium parasite are described. Also, compositions and methods for attracting mosquitos are also described.
    Type: Application
    Filed: August 27, 2018
    Publication date: May 6, 2021
    Applicant: Washington University
    Inventors: Audrey Odom John, Chad Schaber, Indi Trehan, Baranidharan Raman, Nalin Katta
  • Methods and compounds for treating malaria
    Patent number: 10813941
    Abstract: A pharmaceutical composition includes a small molecule and a pharmaceutically acceptable excipient. The small molecule interacts with a deoxyxylulose phosphate reductoisomerase (Dxr). A method for treating or preventing a microbial infection in a subject in need thereof includes administering the pharmaceutical composition. A method for inhibiting the growth of a eukaryotic pathogen includes contacting the eukaryotic pathogen with an effective amount of the pharmaceutical composition.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: October 27, 2020
    Assignees: The George Washington University, A Congressionally Chartered Not-For-Profit Corporation, Washington University in St. Louis
    Inventors: Cynthia Dowd, Audrey Odom, Rachel Edwards, Robert Brothers
  • METHODS AND COMPOUNDS FOR TREATING MALARIA
    Publication number: 20190030056
    Abstract: A pharmaceutical composition includes a small molecule and a pharmaceutically acceptable excipient. The small molecule interacts with a deoxyxylulose phosphate reductoisomerase (Dxr). A method for treating or preventing a microbial infection in a subject in need thereof includes administering the pharmaceutical composition. A method for inhibiting the growth of a eukaryotic pathogen includes contacting the eukaryotic pathogen with an effective amount of the pharmaceutical composition.
    Type: Application
    Filed: January 23, 2017
    Publication date: January 31, 2019
    Applicants: THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALL A CONGRESSIOY CHARTERED NOT-FOR-PROFIT CORPORATIO, WASHINGTON UNIVERSITY IN ST. LOUIS
    Inventors: Cynthia DOWD, Audrey ODOM, Rachel Edwards, Robert BROTHERS
  • TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY
    Publication number: 20170136030
    Abstract: Compounds are disclosed that inhibit the methylerythritol cytidyltransferase (IspD) enzyme in the non-mevalonate pathway (MEP pathway), which is present in many organisms including the P. falciparum parasite. Inhibitors of the IspD enzyme in the non-mevalonate pathway of the P. falciparum parasite are useful for treating malaria.
    Type: Application
    Filed: October 21, 2016
    Publication date: May 18, 2017
    Applicants: Washington University, University of Liverpool
    Inventors: Audrey Odom, Paul O'Neill, Neil Berry
  • TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY
    Publication number: 20160046651
    Abstract: Compounds are disclosed that inhibit the methylerythritol cytidyltransferase (IspD) enzyme in the non-mevalonate pathway (MEP pathway), which is present in many organisms including the P. falciparum parasite. Inhibitors of the IspD enzyme in the non-mevalonate pathway of the P. falciparum parasite are useful for treating malaria.
    Type: Application
    Filed: July 21, 2015
    Publication date: February 18, 2016
    Inventors: Audrey Odom, Paul O'Neill, Neil Berry